Stocks and Investing Stocks and Investing
Thu, August 5, 2021
Wed, August 4, 2021

Drew Ranieri Maintained (AVNS) at Sell with Decreased Target to $41 on, Aug 4th, 2021


Published on 2024-10-27 17:30:22 - WOPRAI, Drew Ranieri
  Print publication without navigation


Drew Ranieri of Morgan Stanley, Maintained "Avanos Medical, Inc." (AVNS) at Sell with Decreased Target from $45 to $41 on, Aug 4th, 2021.

Drew, nor any peers, have made any analyst calls on AVNS in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources